Clinical Trial Update: A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial evaluating the safety and efficacy of T60c Injection in patients with malignant solid tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumors

Drugs mentioned

• T60c Injection

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Malignant Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN